Research Output per year
Fingerprint Dive into the research topics where Medicine, Hepatology Division is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Liver
Medicine & Life Sciences
Liver Transplantation
Medicine & Life Sciences
Hepatocellular Carcinoma
Medicine & Life Sciences
Hepacivirus
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
Liver Diseases
Medicine & Life Sciences
Fibrosis
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Justin Richard Boike
- Medicine, Hepatology Division - Assistant Professor
- Medicine, Gastroenterology Division - Assistant Professor
Person: Academic
Daniel R Ganger
- Medicine, Hepatology Division - Professor
- Surgery, Transplant Surgery Division - Professor
Person: Academic
Research Output 1980 2019
2
Citations
(Scopus)
A comprehensive pipeline for translational top-down proteomics from a single blood draw
Toby, T. K., Fornelli, L., Srzentić, K., DeHart, C. J., Levitsky, J., Friedewald, J. J. & Kelleher, N. L., Jan 1 2019, In : Nature Protocols. 14, 1, p. 119-152 34 p.Research output: Contribution to journal › Article
Proteomics
Blood
Pipelines
Fractionation
Mass spectrometry
5
Citations
(Scopus)
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
American Gastroenterological Association Institute Clinical Guidelines Committee, Feb 1 2019, In : Gastroenterology. 156, 3, p. 748-764 17 p.Research output: Contribution to journal › Article
Ulcerative Colitis
Practice Guidelines
6
Citations
(Scopus)
Age and liver transplantation
Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O. & Francoz, C., Apr 1 2019, In : Journal of Hepatology. 70, 4, p. 745-758 14 p.Research output: Contribution to journal › Review article
Liver Transplantation
Tissue Donors
Transplants
End Stage Liver Disease
Brain Death
Grants 2002 2024
Prot#18-0108: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Two Doses of NGM282 Administered for 24 Weeks for the Treatment of Histologically Confirmed Nonalcoholic Steat
Medpace Clinical Research LLC, NGM Biopharmaceuticals, Inc.
8/23/19 → 8/23/22
Project: Research project
Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC
Collins, J. D., Caicedo, J. C., Katariya, N. N., Kherad Pezhouh, M., Kulik, L. M., Lewandowski, R. J., Markl, M., Miller, F. H. & Ragin, A. B.
8/1/19 → 7/31/24
Project: Research project
Hypertrophy
Hepatocellular Carcinoma
Radiation
Liver
Glass
Metabolic biomarkers as predictors of Nash recurrence after liver transplant
American College of Gastroenterology
7/1/19 → 6/30/20
Project: Research project
Biomarkers
Transplants
Recurrence
Liver
Lipids